Silver Book Fact

The U.S. Food and Drug Administration has approved 5 drugs for the treatment of Alzheimer’s disease. These drugs have been found to temporarily slow the worsening of Alzheimer’s symptoms for an average of 6-12 months, for around 1/2 of those individuals who take the drugs.

Alzheimer's Association. 2009 Alzheimer’s Disease Facts and Figures. Alzheimers Dement. 2009; 5(3): 234-70. http://www.alzheimersanddementia.com/article/S1552-5260(09)00074-0/fulltext

Reference

Title
2009 Alzheimer’s Disease Facts and Figures
Publication
Alzheimers Dement
Publication Date
2009
Authors
Alzheimer's Association
Volume & Issue
Volume 5, Issue 3
Pages
234-70
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Donepezil, a cholinesterase inhibitor, has been found to slow progression of Alzheimer’s disease in its early stages, delaying the need for nursing home care by an average of 30 months.  
  • If an Alzheimer’s disease treatment breakthrough that delayed the age of onset by 5 years was introduced in 2015, by 2020 total cost of care (for all payers) for all people…  
  • According to the Pharmaceutical Research and Manufacturers of America, 42 medicines are currently in development for Alzheimer’s disease.  
  • Studies have shown that active medical management of Alzheimer’s disease can significantly improve quality-of-life for the individual through all stages of the disease.  
  • Research breakthroughs that slow the onset and progression of Alzheimer’s disease could achieve annual Medicare savings of $51 billion by 2015, $126 billion by 2025, and $444 billion by 2050.